Insulin Resistance in Pulmonary Arterial Hypertension



Status:Archived
Conditions:High Blood Pressure (Hypertension), Endocrine
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:September 2008

Use our guide to learn which trials are right for you!

The Effect of Bosentan and Pioglitazone on Insulin Resistance in Pulmonary Arterial Hypertension


The purpose of this study is to evaluate 1) the incidence of insulin resistance (a
pre-diabetic state) in patients with pulmonary hypertension, and 2) test the utility of a
validated PH therapy (Tracleer) versus Pioglitazone in the treatment of those patients found
to have insulin resistance.



We found this trial at
1
site
300 Pasteur Dr
Stanford, California 94305
(650) 723-4000
Stanford university Hospital and Clinics Throughout our history, we have pioneered medical advances that save...
?
mi
from
Stanford, CA
Click here to add this to my saved trials